Outcome of pulmonary tuberculosis treatment in the tertiary care setting — Toronto 1992/93
| Table 1: Characteristics of patients with pulmonary tuberculosis (TB) from 5 tertiarycare centres in Toronto in 1992/93 | ||||||
| Characteristic | Group | |||||
| All patients n = 145 | Born outside Canada n = 102 | HIV positive n = 22 | ||||
| Mean (and median) age, yr* | 45 | (41) | 45 | (37) | 35 | (32) |
| No. (and %) male* | 109 | (75) | 71 | (70) | 22 | (100) |
| No. (and %) homeless† | 14 | (10) | 5 | (5) | 1 | (4) |
| No. (and %) injection drug users† | 13 | (9) | 3 | (3) | 4 | (18) |
| No. (and %) with previous TB | 19 | (13) | 16 | (16) | 2 | (9) |
| No. (and %) with > 1 risk factor | 51 | (35) | 36 | (35) | 15 | (68) |
| No. (and %) presented with symptoms | 112/135 | (83) | 83 | (81) | 17 | (77) |
| Mean (and median) duration of symptoms, wk* | 12 | (6) | 13 | (6) | 6 | (3) |
| No. (and %) with chest x-ray changes typical for TB* | 82/125 | (66) | 64/95 | (67) | 4/20 | (20) |
| No. (and %) with Mycobacterium tuberculosis resistant to >= 1 first-line agent | 12/120 | (10) | 11/89 | (12) | 3/21 | (14) |
| No. (and %) in hospital at time of diagnosis | 91 | (63) | 60 | (59) | 16 | (73) |
| Mean (and median) treatment duration for those who completed treatment, wk* | 44 | (40) | 41 | (40) | 63 | (53) |
| *p< 0.05, comparing HIV-infected patients and those without HIV infection. †p< 0.05, comparing foreign-born and Canadian-born patients. | ||||||
